Kahn Brothers Kahn Brothers Group
Kahn Brothers Group is a value investment firm founded in the tradition of Benjamin Graham and long associated with the Kahn family of investors. The firm is known for deep-value security analysis, patience, and a multi-decade orientation to intrinsic value. Its filings are followed by classic value investors seeking Graham-and-Dodd style managers still active in public markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Patterson-UTI
PTEN
|
+$7.2M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$2.56M |
| 3 |
VRAY
ViewRay, Inc.
VRAY
|
+$1.35M |
| 4 |
FLG
Flagstar Bank National Association
FLG
|
+$871K |
| 5 |
Verizon
VZ
|
+$772K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$726M |
| 2 |
New York Times
NYT
|
+$4.15M |
| 3 |
Citigroup
C
|
+$2.86M |
| 4 |
HOLX
Hologic
HOLX
|
+$1.47M |
| 5 |
STL
Sterling Bancorp
STL
|
+$1.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 34.75% |
| 2 | Healthcare | 32.85% |
| 3 | Energy | 11.11% |
| 4 | Consumer Staples | 7.29% |
| 5 | Technology | 6.17% |
Similar funds
Kahn Brothers's Q3 2019 Portfolio in Review
As of Q3 2019, Kahn Brothers held 48 positions worth $798M, down 0.29% from $800M the previous quarter. Its ten largest holdings account for 79% of the portfolio.
Kahn Brothers withdrew a net $724M in Q3 2019, reducing 15 holdings. Its largest reduction was Merck, cutting an estimated $726M.
By sector, the portfolio is most concentrated in Financials at 35% of assets, up from 33% a quarter earlier, followed by Healthcare and Energy.
Against the trend, Kahn Brothers opened a new position in PepsiCo worth $288K.
- Kahn Brothers's largest Q3 2019 buy was PepsiCo: 2,100 shares worth $288K.
- Kahn Brothers added most to Patterson-UTI in Q3 2019, an estimated $7.2M increase.
- Kahn Brothers's biggest Q3 2019 reduction was Merck, cutting an estimated $726M.
- Kahn Brothers's ten largest holdings make up 79% of its $798M portfolio in Q3 2019.
- Kahn Brothers opened 4 new positions and closed 0 in Q3 2019.
- Kahn Brothers's portfolio value fell 0.29% quarter-over-quarter to $798M.
Based on Kahn Brothers Group's 13F filing for Q3 2019, filed 4 Nov 2019.